In vivo and in vitro experiments demonstrated that ox-LDL could activate the NF-κB signaling pathway via LOX-1, with subsequent upregulation of VEGF-C and promotion of the lymphatic metastasis of gastric cancer (21). This evidence concerns the gene OLR1 and gastric cancer.